The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Srinidhi Fine- Chemicals Llp & Other
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Novelix Pharmaceuticals informed BSE about a Regulation 29(2) disclosure filed by Srinidhi Fine-Chemicals LLP (Promoter) and Narahari Belide (Promoter Group). They were allotted a total of 9,50,000 equity shares on 29th May 2026 on conversion of warrants issued earlier through preferential allotment. Srinidhi Fine-Chemicals received 8,00,000 shares, while Narahari Belide received 1,50,000 shares. After this allotment, their combined shareholding stands at 36.42% of the voting capital (41.08% on a fully diluted basis). The company's total equity share capital increased from Rs. 21.08 crore to Rs. 23.89 crore, with 23,89,500 equity shares now outstanding plus 33,75,000 convertible warrants still pending.
This is a positive signal as promoters are increasing their stake by exercising warrants, showing continued confidence in the company. However, their percentage holding slightly diluted from 36.68% to 36.42% because the company also issued shares to others during this preferential allotment.